The estimated Net Worth of Roger W Brimblecombe is at least $1.58 Milion dollars as of 27 May 2008. Roger Brimblecombe owns over 3,333 units of Vertex Pharmaceuticals stock worth over $1,582,308 and over the last 21 years Roger sold VRTX stock worth over $0.
Roger has made over 5 trades of the Vertex Pharmaceuticals stock since 2006, according to the Form 4 filled with the SEC. Most recently Roger exercised 3,333 units of VRTX stock worth $47,329 on 27 May 2008.
The largest trade Roger's ever made was exercising 27,500 units of Vertex Pharmaceuticals stock on 13 February 2006 worth over $301,950. On average, Roger trades about 3,654 units every 64 days since 2003. As of 27 May 2008 Roger still owns at least 3,333 units of Vertex Pharmaceuticals stock.
You can see the complete history of Roger Brimblecombe stock trades at the bottom of the page.
Roger's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden a Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: